Literature DB >> 9421395

Osteocalcin production in primary osteoblast cultures derived from normal and Hyp mice.

T O Carpenter1, K C Moltz, B Ellis, M Andreoli, T L McCarthy, M Centrella, D Bryan, C M Gundberg.   

Abstract

Rickets and osteomalacia are characteristic features of the Hyp mouse model of human X-linked hypophosphatemia. Hyp mice demonstrate elevated circulating osteocalcin levels, as well as altered regulation of osteocalcin by 1,25(OH)2D3. Whether this osteocalcin abnormality is intrinsic to the osteoblast, or mediated by the in vivo milieu, has not been established. We therefore characterized osteocalcin production and its regulation by 1,25(OH)2D3 in primary cultures of murine osteoblasts and examined osteocalcin and its messenger RNA in response to 1,25(OH)2D3 in cultures of Hyp mouse-derived osteoblasts. Cell viability and osteocalcin production are optimal when murine cells are harvested within 36 h of age. Murine primary osteoblast cultures mineralize and produce osteocalcin in a maturation-dependent fashion (as demonstrated in other species), and continuous exposure to 1,25(OH)2D3, beginning at day 9 of culture, inhibits osteoblast differentiation and osteocalcin production and prevents mineralization of the culture. However, in contrast to other species, exposure to 1,25(OH)2D3, added later (days 17-25) in culture, does not stimulate osteocalcin but arrests osteocalcin production at current levels. Ambient media levels of osteocalcin were no different in cultures from Hyp mice and their normal litter mates, and the down-regulatory response to 1,25(OH)2D3 was comparable in cultures from normal and Hyp mice. Furthermore, expression of osteocalcin messenger RNA in murine cultures is reduced with exposure to 1,25(OH)2D3, and there is no difference between normal and Hyp cultures in this response. Thus, primary murine osteoblasts manifest a species-specific effect of 1,25(OH)2D3 on osteocalcin production. Furthermore, the increased serum osteocalcin production seen in intact Hyp mice, and the altered response to 1,25(OH)2D3 in Hyp mice, are not observed in osteoblast cultures derived from the mutant strain. These data indicate that abnormalities of osteocalcin described in intact Hyp mice require factors other than those present in cultured cells.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1998        PMID: 9421395     DOI: 10.1210/endo.139.1.5677

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Comparative effect of human platelet derivatives on proliferation and osteogenic differentiation of menstrual blood-derived stem cells.

Authors:  Somaieh Kazemnejad; Roghaieh Najafi; Amir Hassan Zarnani; Saman Eghtesad
Journal:  Mol Biotechnol       Date:  2014-03       Impact factor: 2.695

2.  Expression of an estrogen receptor agonist in differentiating osteoblast cultures.

Authors:  Thomas L McCarthy; Mary E Clough; Caren M Gundberg; Michael Centrella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

3.  Stratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts.

Authors:  Thomas L McCarthy; Zhong Yun; Joseph A Madri; Michael Centrella
Journal:  Gene       Date:  2014-01-15       Impact factor: 3.688

4.  Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.

Authors:  Peter S N Rowe; Naoko Matsumoto; Oak D Jo; Remi N J Shih; Jeannine Oconnor; Martine P Roudier; Steve Bain; Shiguang Liu; Jody Harrison; Norimoto Yanagawa
Journal:  Bone       Date:  2006-06-09       Impact factor: 4.398

5.  β-Catenin independent cross-control between the estradiol and Wnt pathways in osteoblasts.

Authors:  Thomas L McCarthy; Caleb B Kallen; Michael Centrella
Journal:  Gene       Date:  2011-02-16       Impact factor: 3.688

6.  Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation.

Authors:  Susan X Hsiong; Tanyarut Boontheekul; Nathaniel Huebsch; David J Mooney
Journal:  Tissue Eng Part A       Date:  2009-02       Impact factor: 3.845

Review 7.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

8.  Novel links among Wnt and TGF-beta signaling and Runx2.

Authors:  Thomas L McCarthy; Michael Centrella
Journal:  Mol Endocrinol       Date:  2010-01-21

9.  MEPE has the properties of an osteoblastic phosphatonin and minhibin.

Authors:  P S N Rowe; Y Kumagai; G Gutierrez; I R Garrett; R Blacher; D Rosen; J Cundy; S Navvab; D Chen; M K Drezner; L D Quarles; G R Mundy
Journal:  Bone       Date:  2004-02       Impact factor: 4.398

10.  Defining the Properties of an Array of -NH2-Modified Substrates for the Induction of a Mature Osteoblast/Osteocyte Phenotype from a Primary Human Osteoblast Population Using Controlled Nanotopography and Surface Chemistry.

Authors:  Sandra A Fawcett; Judith M Curran; Rui Chen; Nicholas P Rhodes; Mark F Murphy; Peter Wilson; Lakshminarayan Ranganath; Jane P Dillon; James A Gallagher; John A Hunt
Journal:  Calcif Tissue Int       Date:  2016-10-28       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.